Wen Qiu Selected Research

Complement Membrane Attack Complex (Membrane Attack Complex)

1/2021	Sublytic C5b-9 induces glomerular mesangial cell proliferation via ERK1/2-dependent SOX9 phosphorylation and acetylation by enhancing Cyclin D1 in rat Thy-1 nephritis.
1/2021	Sublytic C5b-9 triggers glomerular mesangial cell proliferation via enhancing FGF1 and PDGFα gene transcription mediated by GCN5-dependent SOX9 acetylation in rat Thy-1 nephritis.
1/2019	Sublytic C5b-9 induces proliferation of glomerular mesangial cells via ERK5/MZF1/RGC-32 axis activated by FBXO28-TRAF6 complex.
12/2018	Sublytic C5b-9 Induces IL-23 and IL-36a Production by Glomerular Mesangial Cells via PCAF-Mediated KLF4 Acetylation in Rat Thy-1 Nephritis.
1/2018	Sublytic C5b-9 Induces Glomerular Mesangial Cell Apoptosis Through miR-3546/SOX4/Survivin Axis in Rat Thy-1 Nephritis.
1/2017	Sublytic C5b-9 Induces Glomerular Mesangial Cell Apoptosis through the Cascade Pathway of MEKK2-p38 MAPK-IRF-1-TRADD-Caspase 8 in Rat Thy-1 Nephritis.
12/2016	Sublytic C5b-9 triggers glomerular mesangial cell apoptosis in rat Thy-1 nephritis via Gadd45 activation mediated by Egr-1 and p300-dependent ATF3 acetylation.
3/2014	Sublytic C5b-9 induces IL-6 and TGF-β1 production by glomerular mesangial cells in rat Thy-1 nephritis through p300-mediated C/EBPβ acetylation.
5/2012	Sublytic C5b-9 complexes induce apoptosis of glomerular mesangial cells in rats with Thy-1 nephritis through role of interferon regulatory factor-1-dependent caspase 8 activation.
3/2012	Sublytic C5b-9 complexes induce proliferative changes of glomerular mesangial cells in rat Thy-1 nephritis through TRAF6-mediated PI3K-dependent Akt1 activation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Wen Qiu Research Topics

Disease

14	Nephritis 01/2021 - 11/2009
8	Neoplasms (Cancer) 01/2021 - 02/2008
7	Glomerulonephritis 01/2021 - 03/2012
2	Proteinuria 01/2022 - 01/2020
2	Breast Neoplasms (Breast Cancer) 01/2022 - 01/2021
2	Congenital Abnormalities (Deformity) 01/2020 - 01/2020
2	Glioma (Gliomas) 10/2019 - 10/2016
2	Inflammation (Inflammations) 01/2018 - 10/2014
2	Infections 05/2017 - 01/2013
2	Multiple Sclerosis 05/2017 - 10/2014
2	Hypoxia (Hypoxemia) 05/2017 - 08/2013
2	Tuberculosis (Tuberculoses) 09/2013 - 01/2013
2	Ovarian Neoplasms (Ovarian Cancer) 11/2008 - 08/2007
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2022
1	Hypotension (Low Blood Pressure) 01/2022
1	Heart Failure 01/2022
1	Dysbiosis 01/2022
1	Weight Gain 01/2022
1	Premature Ejaculation 10/2021
1	Urinary Bladder Neoplasms (Bladder Cancer) 01/2021
1	Experimental Arthritis 01/2021
1	Arthritis (Polyarthritis) 01/2021
1	Type 2 Diabetes Mellitus (MODY) 01/2020
1	Malignant Pleural Effusion 08/2018
1	Encephalomyelitis (Myeloencephalitis) 05/2017
1	Diabetic Nephropathies (Diabetic Nephropathy) 01/2017
1	Paroxysmal Hemoglobinuria (Paroxysmal Nocturnal Hemoglobinuria) 01/2017
1	Hemolysis 01/2017
1	Glioblastoma (Glioblastoma Multiforme) 10/2016
1	Demyelinating Diseases (Demyelinating Disease) 10/2014
1	Autoimmune Diseases (Autoimmune Disease) 10/2014
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 10/2014
1	Chronic Pain 01/2014
1	Pain (Aches) 01/2014
1	Carcinoma (Carcinomatosis) 03/2011
1	Sick Building Syndrome 01/2009

Drug/Important Bio-Agent (IBA)

12	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2021 - 11/2009
5	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2008
4	AntigensIBA 01/2021 - 09/2013
3	Interleukin-6 (Interleukin 6)IBA 01/2021 - 03/2014
3	DNA (Deoxyribonucleic Acid)IBA 01/2020 - 08/2007
3	Interleukin-17 (Interleukin 17)IBA 10/2019 - 10/2014
3	Complement System Proteins (Complement)IBA 01/2018 - 11/2009
2	MicroRNAs (MicroRNA)IBA 07/2022 - 10/2014
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 08/2013
2	CytokinesIBA 10/2019 - 12/2018
2	VaccinesIBA 01/2017 - 01/2013
2	EnzymesIBA 10/2014 - 08/2013
2	DNA VaccinesIBA 09/2013 - 01/2013
2	Peptides (Polypeptides)IBA 09/2013 - 02/2008
1	ErbB Receptors (EGF Receptor)IBA 07/2022
1	Biomarkers (Surrogate Marker)IBA 07/2022
1	Aminophylline (Carine)FDA LinkGeneric 01/2022
1	DiureticsIBA 01/2022
1	Nicorandil (SG 75)IBA 01/2022
1	interferon regulatory factor-8 (interferon consensus sequence binding protein)IBA 01/2022
1	dapoxetineIBA 10/2021
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2021
1	Fibroblast Growth Factor 1 (FGF-1)IBA 01/2021
1	AdiponectinIBA 01/2021
1	Cisplatin (Platino)FDA LinkGeneric 01/2021
1	Cyclin D1IBA 01/2021
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2021
1	Chemokine CCL5IBA 01/2020
1	glimepiride (Amarel)FDA LinkGeneric 01/2020
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2020
1	Interleukin-23 (Interleukin 23)IBA 12/2018
1	ProcalcitoninIBA 08/2018
1	Anaphylatoxin C5a ReceptorIBA 01/2018
1	SurvivinIBA 01/2018
1	Retinaldehyde (Retinal)IBA 01/2018
1	Complement C5 (Complement 5)IBA 01/2017
1	Insulin (Novolin)FDA Link 01/2017
1	Monoclonal AntibodiesIBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	eculizumab FDA Link 01/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	demethoxycurcuminIBA 10/2016
1	Temozolomide (Temodar)FDA LinkGeneric 10/2016
1	Small Interfering RNA (siRNA)IBA 10/2014
1	UbiquitinIBA 10/2014
1	Pain-FreeIBA 01/2014
1	EpitopesIBA 09/2013
1	SuspensionsIBA 08/2013
1	ChitosanIBA 01/2013
1	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 01/2013
1	Caspase 8 (Caspase-8)IBA 05/2012
1	InterferonsIBA 05/2012
1	Thrombospondin 1IBA 11/2011
1	Biological ProductsIBA 03/2011
1	Formaldehyde (Formol)FDA Link 01/2009
1	Organic Chemicals (Chemicals, Organic)IBA 01/2009
1	DNA HelicasesIBA 11/2008
1	hydrogen sulfite (bisulfite)IBA 11/2008
1	Anti-Infective Agents (Microbicides)IBA 02/2008

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2021
1	Intra-Articular Injections 01/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Lasers (Laser) 01/2018
1	Aftercare (After-Treatment) 10/2016